Mounjaro Coupon Card: Savings Limits Explained

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Wegovy has a list price of about $1,350 per month for both the weekly injection pen and the daily pill.
Without insurance, cash-pay prices in 2026 typically range from about $199–$349 per month for the injection pen and $149–$299 for the pill.
The Wegovy savings program can save up to $55 per fill off the retail price.
With insurance, the estimated monthly price for Wegovy is $25–$150, but this varies by plan and coverage.

Understanding the cost of GLP-1 medications like Wegovy is a major concern for many people looking into weight management or diabetes treatment. The list price for Wegovy, whether it’s the weekly injection pen or the daily pill, is around $1,350 per month. However, this is rarely what people actually pay. Savings programs and insurance coverage can significantly reduce this amount. For instance, the Wegovy savings program can help you save up to $55 off the retail price per fill. Without insurance, cash-pay prices in 2026 for the injection pen typically range from about $199 to $349 per month, while the pill might cost $149 to $299 monthly. When insurance is involved, the monthly cost can drop to $25–$150, but this depends heavily on your specific plan and its coverage for weight-loss medications.

What is the List Price of Wegovy?

The retail price of Wegovy is $1,349. This is the official cost set by the manufacturer before any discounts, insurance, or savings programs are applied. This price applies to both the weekly injection pen and the daily pill forms of the medication. It's important to understand that this list price is often higher than what most people will actually pay, especially if they have insurance or qualify for patient assistance programs. Several factors can influence the final price a person pays, including their specific treatment plan, the type of insurance coverage they have, and even the pharmacy they choose to use.

Understanding the Base Cost of Wegovy

Wegovy's list price is about $1,350 per month for both the weekly injection pen and the daily pill. This figure represents the starting point for cost discussions. When considering GLP-1 medications, it's crucial to distinguish between the list price and what is known as the "cash-pay" or "out-of-pocket" price. The list price is a benchmark, but various pathways exist to reduce the actual expenditure. For example, without insurance, cash-pay prices for the Wegovy injection pen in 2026 might range from $199 to $349 per month, which is significantly lower than the list price. Similarly, the Wegovy pill, which was approved in late 2025, has estimated cash-pay prices without insurance ranging from $149 to $299 per month. These lower cash-pay prices are often available through specific manufacturer programs or pharmacies that offer direct-to-consumer options.

The cost of any medication, including Wegovy, is not fixed for everyone. Your specific treatment plan, such as the dosage or duration of use, could subtly influence the overall cost over time. More significantly, your insurance coverage plays a critical role in determining what you will pay. Some insurance plans may cover a large portion of the cost, while others may not cover weight-loss medications at all. Even the pharmacy you use can affect the final price. Different pharmacies may have different pricing agreements or offer varying discounts, even for the same medication. Therefore, it is always a good idea to speak with your doctor, pharmacist, and insurance provider to get a clear understanding of what your personal cost for Wegovy will be. This proactive approach can help you budget effectively and avoid surprises when filling your prescription.

The landscape of drug pricing is constantly evolving due to government regulations, manufacturer initiatives, and changes in pharmacy practices. Staying informed about these shifts is key to making a well-informed decision about whether Wegovy fits your budget. For many, the high list price can be daunting, but exploring all available savings options is essential before ruling out this effective weight management treatment.

How Do Savings Programs and Coupons Help with Wegovy Costs?

Savings programs and coupons can significantly reduce the out-of-pocket cost of Wegovy, making it more accessible for many patients. The official Wegovy savings program, for example, allows eligible individuals to save up to $55 per fill off the retail price. These programs are designed to help offset the high list price of the medication, especially for those who might otherwise struggle to afford it. Beyond manufacturer programs, many prescription discount websites offer coupons that can further reduce costs. However, it is important to note that these coupons typically cannot be used in combination with insurance copays or benefits. In some cases, the discounted price offered by these coupons might even be lower than what you would pay through your insurance plan, so it's worth comparing.

Leveraging Manufacturer Savings Programs

Novo Nordisk, the maker of Wegovy, offers specific programs to help patients manage costs. The Wegovy savings program is a prime example, providing a direct discount of up to $55 per fill. To qualify for such programs, patients usually need to meet certain eligibility criteria, which often include having commercial insurance and not being enrolled in government healthcare programs like Medicare or Medicaid. These programs are designed to assist patients with their out-of-pocket expenses, reducing the financial burden at the pharmacy counter. We find that understanding the specific terms and conditions of these manufacturer programs is crucial, as they can vary and may have annual limits or other restrictions. Wegovy Cost & Coverage Information provides additional details on how to navigate these options.

Exploring Prescription Discount Websites

In addition to manufacturer programs, a variety of prescription discount websites offer coupons that can lower the cost of Wegovy. These online platforms aggregate discounts from various sources, providing patients with printable coupons or digital codes to use at participating pharmacies. While these coupons can offer substantial savings, a key limitation is that they generally cannot be combined with your insurance benefits. This means you typically have to choose between using your insurance coverage or using the discount coupon. For some, the cash price with a discount coupon may be more favorable than their insurance copay, especially if their insurance plan has a high deductible or limited coverage for GLP-1 medications. It's always advisable to check both options—your insurance copay and the coupon price—before filling your prescription to determine the most cost-effective path.

Understanding Cash-Pay Options Through Manufacturer Pharmacies

Novo Nordisk also offers specific cash-pay options, often through their NovoCare Pharmacy. For those without insurance or whose plans do not cover weight-loss medications, these programs can be a lifeline. In 2026, for example, the estimated cash-pay prices without insurance for the Wegovy injection pen through NovoNordisk’s NovoCare Pharmacy range from about $199 to $349 per month. For the Wegovy pill, the cash-pay prices are estimated to be $149 to $299 per month. These prices are significantly lower than the list price of $1,350 per month and represent a direct attempt by the manufacturer to make the medication more affordable for those paying entirely out of pocket. These options reflect a shifting landscape in drug pricing, where manufacturers are increasingly offering direct pathways to lower costs for consumers, especially in areas where insurance coverage is inconsistent or absent.

What Are Wegovy's Costs Without Insurance in 2026?

For individuals without insurance coverage, or whose insurance plans do not cover weight-loss medications, the cash-pay price for Wegovy in 2026 has seen some shifts. Without insurance, the cash-pay prices for the weekly Wegovy injection pen typically range from about $199 to $349 per month. This is a significant reduction from the medication's list price of approximately $1,350. Similarly, for the new Wegovy pill, which was approved in late 2025, cash-pay prices without insurance are generally between $149 and $299 per month. These more affordable cash-pay options are often available through specific programs, such as NovoNordisk’s NovoCare Pharmacy.

Cash-Pay for the Wegovy Injection Pen

The cost of the Wegovy injection pen without insurance has become more manageable for many. In 2026, patients paying cash can expect prices ranging from about $199 to $349 per month. This pricing reflects changes in government regulations, manufacturer programs, and how pharmacies handle cash-pay prescriptions. It’s a considerable difference from the sticker shock of the $1,350 list price. These cash-pay options are a crucial development for those who are uninsured or whose insurance policies specifically exclude coverage for weight-loss treatments. When we compare this to the list price, it highlights the impact of direct manufacturer programs aimed at improving access. These programs often streamline the process for patients to obtain their medication at a more affordable rate, bypassing the complexities of insurance negotiations.

Cash-Pay for the Wegovy Pill

The introduction of the Wegovy pill, approved in late 2025, adds another option for patients, and its cash-pay pricing without insurance is also competitive. For the pill form, individuals can expect to pay between $149 and $299 per month in 2026. This provides a potentially even more affordable alternative to the injection pen for those paying out of pocket. The choice between the daily pill and the weekly injection pen will depend on individual preference, medical needs, and the specific pricing available at the time of prescription. The availability of both forms with competitive cash-pay pricing demonstrates a broader effort to make GLP-1 medications more accessible across different patient needs and financial situations. This flexibility can be a major factor for individuals weighing their treatment options.

Navigating Cash-Pay Through NovoNordisk’s NovoCare Pharmacy

Many of the more affordable cash-pay prices for Wegovy, both the injection and the pill, are made available through NovoNordisk’s NovoCare Pharmacy. This direct channel from the manufacturer often provides the most transparent and lowest cash prices for patients without insurance. It’s a valuable resource for understanding true out-of-pocket options. The pharmaceutical industry has been adapting to market demands for more affordable access, and direct pharmacy programs are one way this is being achieved. Patients considering Wegovy without insurance should actively explore the options provided by NovoCare Pharmacy to ensure they are getting the best possible price. The focus on direct-to-consumer pricing through such channels reflects a recognition that many patients need alternatives to traditional insurance pathways for expensive medications. Staying informed about these manufacturer-specific programs is key to navigating the cost landscape effectively.

How Does Insurance Coverage Affect Wegovy Prices?

Insurance coverage significantly impacts the final price a patient pays for Wegovy, often reducing it substantially from the list price. With insurance, the estimated monthly price for both the Wegovy injection pen and the pill typically ranges from $25 to $150. However, this range can vary widely based on the specifics of an individual's insurance plan and their particular coverage benefits. While insurance can make Wegovy much more affordable, it's also true that coverage for weight-loss medications has historically been inconsistent, with many plans not accepting claims for this use.

The Role of Insurance Plans in Reducing Costs

When an insurance plan covers Wegovy, it can dramatically lower the patient's out-of-pocket expenses. The difference between the list price of $1,350 and an estimated monthly cost of $25–$150 with insurance is substantial. This reduction is due to the negotiated rates between the insurance company and the pharmaceutical manufacturer, as well as the patient's copay, coinsurance, or deductible structure. A robust insurance plan with good coverage for GLP-1 medications can transform an otherwise unaffordable treatment into a manageable monthly expense. It is crucial for patients to contact their insurance provider directly to understand their specific benefits, including any prior authorization requirements or formulary restrictions that might apply to Wegovy.

Challenges with Insurance Coverage for Weight Loss

Despite the potential for significant savings, obtaining insurance coverage for weight-loss medications like Wegovy can be challenging. Historically, insurance is rarely accepted when a medication is used solely for weight loss. Many insurance policies classify weight management as a lifestyle choice rather than a medical necessity, leading to exclusions for such drugs. This situation has been a major barrier for many patients seeking effective treatment for obesity. However, this landscape is gradually changing, with increasing recognition of obesity as a chronic disease. As public and medical understanding evolves, more insurance plans are beginning to offer some level of coverage for these medications. This shift means that while coverage might still be difficult to secure, it's becoming more common than in previous years. Wegovy cost 2026: Coupons, savings, and more highlights how these factors influence patient costs.

Navigating Prior Authorization Requirements

Even when an insurance plan covers Wegovy, patients often face prior authorization requirements. Prior authorization is a process where the healthcare provider must obtain approval from the insurance company before the medication can be dispensed. This typically involves submitting documentation that justifies the medical necessity of the treatment, such as a patient's BMI, co-existing health conditions, and previous weight-loss attempts. This process can be complex and time-consuming, sometimes leading to delays in treatment. Companies like CoverMyMeds aim to simplify this process, offering web pages and tools to help providers navigate GLP-1 prior authorization challenges. Despite these tools, prior authorization remains a significant hurdle for many, requiring persistent effort from both patients and their healthcare providers to ensure coverage. Understanding these challenges and solutions is key to accessing GLP-1 medications effectively. Navigating GLP-1 Medications: Prior Authorization Challenges and Solutions provides further insight into this complex area.

Are There Other GLP-1 Savings Options, Like Ozempic?

Yes, other GLP-1 medications, such as Ozempic, also offer savings programs that can significantly reduce costs for eligible patients. Ozempic, which contains the same active ingredient as Wegovy (semaglutide) but is primarily indicated for type 2 diabetes, provides a savings card for commercially covered patients. This card allows them to pay as little as $25 for any dose of Ozempic for up to a 3-month prescription. For those who are uninsured or self-paying, new patients for Ozempic 0.25 mg or 0.5 mg can pay $25 per month for the first two months. Ozempic also has specific programs for existing patients at different dosages, further broadening access to this important medication. For more details, see Wegovy Cost Without Insurance in 2026.

Ozempic Savings for Commercially Covered Patients

The Ozempic Savings Card is a valuable resource for individuals with commercial insurance. This program is designed to lower the out-of-pocket costs for patients who have coverage for Ozempic through their health plan. With the savings card, commercially covered patients can pay as little as $25 for their Ozempic prescription, covering up to a 3-month supply. This can translate into substantial savings over a year, making regular treatment much more affordable. Eligibility for this program typically requires patients to have commercial insurance and not be enrolled in government-funded programs like Medicare, Medicaid, or TRICARE. These types of savings cards are common strategies used by pharmaceutical manufacturers to ensure that patients with private insurance can access their medications without facing prohibitively high copays or deductibles. It helps bridge the gap between the insurer's coverage and the patient's financial capabilities.

Ozempic Savings for Uninsured and Self-Pay Patients

For patients who are uninsured or choose to pay for their medication themselves, Ozempic also offers a limited-time savings offer. New patients starting on Ozempic 0.25 mg or 0.5 mg can pay $25 per month for the first two months of treatment. This initial discount can be crucial for patients just beginning their Ozempic journey, helping them get started without a significant upfront financial burden. While this offer is for a limited duration and specific dosages, it provides a much-needed entry point for those without insurance coverage. The availability of such programs demonstrates a commitment to making GLP-1 medications accessible to a broader population, including those outside the traditional insurance framework. After the initial two months, patients would need to explore other savings avenues or pay the full cash price, but this introductory offer can be a significant help.

Ozempic Programs for Existing Patients and Different Dosages

Ozempic's savings programs extend beyond new patients and initial dosages. There are also specific savings opportunities for existing patients and those on higher doses, such as Ozempic 1 mg or 2 mg. These varied programs ensure that ongoing treatment remains as affordable as possible, regardless of the dosage required. The ability to save on different dosages and for both new and existing patients makes Ozempic a more financially viable option for many. When we consider the broader landscape of GLP-1 medications, these diverse savings programs are vital. They help patients maintain adherence to their treatment plans by reducing financial barriers over the long term. Patients are encouraged to visit the official Ozempic website, Ozempic® Savings Card | Ozempic® (semaglutide) injection, for the most up-to-date information on eligibility and terms for all their savings programs. This ensures they can take full advantage of any available discounts throughout their treatment journey.

What are Important Safety Considerations for Wegovy?

Wegovy, while effective for weight management, carries important safety considerations and potential serious side effects that patients must be aware of. One of the most critical concerns is the possibility of thyroid tumors, including cancer. Studies in rodents have shown that Wegovy and similar medications can cause thyroid tumors, including thyroid cancer. It is not yet known if Wegovy will cause these types of tumors, specifically medullary thyroid carcinoma (MTC), in humans. Patients should immediately tell their healthcare provider if they notice a lump or swelling in their neck, experience hoarseness, have trouble swallowing, or feel short of breath, as these could be symptoms of thyroid cancer.

Contraindications and Allergic Reactions

There are specific situations where Wegovy should not be used. Patients or their family members who have a history of medullary thyroid carcinoma (MTC) should not take Wegovy. Similarly, individuals with an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) are advised against using this medication. These conditions increase the risk of thyroid cancer, making Wegovy unsuitable. Furthermore, anyone who has had a serious allergic reaction to semaglutide, the active ingredient in Wegovy, or any other ingredients in the injection or tablets, should avoid using the medication. Symptoms of a serious allergic reaction can include swelling of the face, lips, tongue, or throat, severe rash or itching, problems breathing or swallowing, or dizziness and fainting. It is crucial to inform your healthcare provider about any allergies before starting treatment.

Other Medical Conditions and Interactions

Before starting Wegovy, it is essential to discuss your complete medical history with your healthcare provider. This includes any past or current problems with your pancreas or kidneys, as Wegovy can affect these organs. Patients with type 2 diabetes who also have a history of diabetic retinopathy should also inform their doctor. If you are scheduled for surgery or other procedures that require anesthesia or deep sedation, your healthcare provider needs to know you are taking Wegovy. This is because Wegovy slows stomach emptying, which can be a concern with certain medical procedures.

Women who are pregnant or planning to become pregnant should be aware that Wegovy may harm an unborn baby. It is recommended to stop using Wegovy at least 2 months before planning to conceive. For breastfeeding mothers, it is not known if Wegovy, when received through an injection, passes into breast milk, and breastfeeding is generally not recommended during treatment with Wegovy tablets. Additionally, a comprehensive list of all medicines you take, including prescription drugs, over-the-counter medications, vitamins, and herbal supplements, must be shared with your doctor. Wegovy can interact with other medications, especially those for diabetes like sulfonylureas or insulin, and medicines that need to pass through the stomach quickly due to its effect on stomach emptying. This comprehensive disclosure helps your doctor ensure the safe use of Wegovy.

Potential Serious Side Effects

Beyond thyroid concerns, Wegovy may cause other serious side effects. One such effect is inflammation of the pancreas, known as pancreatitis. Patients should immediately stop using Wegovy and contact their healthcare provider if they experience severe pain in their stomach area that does not go away, with or without nausea or vomiting. This pain might sometimes spread from the abdomen to the back. Another potential concern is gallbladder problems, including gallstones. Some gallstones may become severe enough to require surgery. Symptoms to watch for include pain in the upper stomach, fever, yellowing of the skin or eyes (jaundice), or clay-colored stools. Any of these symptoms warrant a call to your healthcare provider right away. Being aware of these serious side effects and knowing when to seek medical attention is vital for anyone considering or currently using Wegovy.

How Do Prior Authorizations Affect GLP-1 Access?

Prior authorizations are a common and often challenging hurdle in accessing GLP-1 medications like Wegovy and Ozempic. These requirements mean that before an insurance company will cover the cost of the medication, your healthcare provider must submit a request and obtain approval. This process is designed by insurers to ensure that the medication is medically necessary and meets specific criteria set by the plan. While they can complicate and delay access, there are solutions and strategies to simplify the prior authorization process, such as utilizing specialized web pages and tools.

Understanding the Prior Authorization Process

Prior authorization essentially acts as a gatekeeper for expensive medications. For GLP-1s, insurance companies often require documentation proving that a patient meets certain clinical criteria, such as a specific Body Mass Index (BMI), presence of weight-related comorbidities (like high blood pressure or type 2 diabetes), or a history of failed attempts with other weight-loss methods. The paperwork involved can be extensive, requiring detailed medical records, physician notes, and sometimes appeals if the initial request is denied. This can be a significant burden on healthcare providers and their administrative staff, leading to delays in patients starting their treatment. The complexity often stems from varying requirements across different insurance plans, making it difficult for providers to keep up with all the specific demands.

Challenges in Securing GLP-1 Prior Authorization

The challenges associated with prior authorizations for GLP-1 medications are well-documented. Providers often spend considerable time filling out forms, gathering patient information, and communicating with insurance companies. This administrative burden can divert resources from direct patient care. Moreover, denials are not uncommon, even when a medication is clearly indicated by clinical guidelines. Reasons for denial can include insufficient documentation, not meeting specific plan criteria, or the plan simply not covering weight-loss medications. These denials can be frustrating for both patients and providers, leading to delays in treatment and potentially discouraging patients from pursuing effective therapies. The process can feel like a bureaucratic maze, designed to limit access rather than facilitate appropriate care.

Solutions to Simplify Prior Authorization

Fortunately, efforts are underway to simplify the prior authorization process for GLP-1 medications. One notable resource is the CoverMyMeds web page, which is specifically designed to streamline prior authorization requests. This platform helps healthcare providers manage and submit prior authorization forms electronically, reducing paper-based processes and improving efficiency. By centralizing the process and providing tools to navigate complex requirements, CoverMyMeds aims to reduce the administrative burden on clinics and pharmacies. Such solutions are critical for improving patient access to GLP-1s, ensuring that delays are minimized and that medically necessary treatments are approved in a timely manner. The goal is to make the process more transparent and less cumbersome, allowing patients to start their prescribed medications without undue obstacles. These tools are a step towards making the system more patient-friendly, despite the inherent complexities of insurance-mandated approvals.

Frequently Asked Questions

What is the average monthly cost of Wegovy without insurance?

Without insurance, the cash-pay price for Wegovy in 2026 typically ranges from about $199–$349 per month for the injection pen. For the new Wegovy pill, the monthly cost without insurance is generally between $149–$299. These prices are significantly lower than the list price of $1,350 and are often available through specific manufacturer programs like NovoNordisk’s NovoCare Pharmacy.

Can I use a Wegovy coupon card with my insurance?

Generally, prescription discount coupons, including those for Wegovy, cannot be combined with insurance copays or benefits. You usually have to choose between using your insurance coverage or using a coupon. However, the discounted price from a coupon might sometimes be lower than your insurance copay, so it is always worth checking both options to find the most affordable price. The Wegovy savings program can save up to $55 per fill off the retail price.

What are the serious side effects of Wegovy?

Wegovy may cause serious side effects, including possible thyroid tumors, such as cancer. Patients should report any neck lumps, hoarseness, trouble swallowing, or shortness of breath to their doctor immediately. Other serious side effects include inflammation of the pancreas (pancreatitis) and gallbladder problems, which can sometimes require surgery.

How much can I save on Ozempic with its savings card?

For commercially covered patients, the Ozempic Savings Card allows them to pay as little as $25 for any dose of Ozempic for up to a 3-month prescription. Uninsured and self-pay new patients for Ozempic 0.25 mg or 0.5 mg can pay $25 per month for the first two months. Programs also exist for existing patients on various dosages.

Are there new subscription plans for Wegovy in 2026?

Yes, the maker of Wegovy has launched lower-cost subscription plans in 2026. While specific details on the structure of these subscription plans are not fully outlined, they are part of a broader effort to make Wegovy more accessible and affordable, especially for those without comprehensive insurance coverage or facing high out-of-pocket costs. These plans aim to provide more predictable monthly expenses.